Klinik Araştırmalar Derneği Uzaktan Eğitim Programları KADUZEM Hakkında Detaylı Bilgi İçin

Son Haberler

Is transparency enough to prevent Drug Companies From Corrupting Medical Research?

  • 14 Sep 18

Dr. José Baselga resigned from his position as chief medical officer at Memorial Sloan Kettering Cancer Center. The New York Times revealed that he’d received millions of dollars from drug and device companies.

Devamı…

Are biomedical researchers spies?

  • 02 Sep 18

NIH Director Francis Collins, briefed the USA committee on the agency's investigation of NIH-funded scientists who may be smuggling intellectual property or unpublished scientific information to foreign governments.

Devamı…

Drug study halted..

  • 10 Aug 18

A drug study in Holland halted due to baby deaths after birth..

Devamı…

TRANSCELERATE approved GCP distance learning programs of Turkish Clinical Research Association..

  • 28 Jul 18

The three GCP distance learning programs of Turkish Clinical Association working under KADUZEM platform are recognized by Transcelerate GCP mutual recognition program. The recognized coursed are Basic GCP, Advanced GCP and Sİte Coordinator GCP courses.

Devamı…

Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry..

  • 24 Jul 18

FDA issued "Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry"

Devamı…

Key strategies for delivering efficient multi-regional clinical trials: EM-Phases Conference - 22-23 October Prag..

  • 02 Jul 18

The EM-Phases Conference will be held in Prag on 22-23 October and Turkey will be represented by Prof. Dr. Hamdi AKan, Prof. Dr. Yağız Üresin and Dr. Betül Erdogan.

Devamı…

FDA Inspections

  • 20 Jun 18

Devamı…

Turkey became an ICH Observer Member..

  • 13 Jun 18

Turkey was elected as an observer member of ICH during the assembly held in Japan.

Devamı…


Klinik Araştırmalar Derneği'nin yeni yenilikci aktiviteleri

Toplamda 25'den fazla olan aktivitelerinden bazıları aşağıdadır.


Videolar


Türkiye Klinik Çalışma Verileri

0